RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 1-11
  • Raising Awareness About Morning Sickness Medication

    Raising Awareness About Morning Sickness Medication
    Reports of Kate Middleton's severe morning sickness opened eyes about how hard pregnancy can be for some women.  "I went to the emergency room because I was so sick and dehydrated after a week of not being able to eat or drink," says Megan Donofrio of...
  • Childhood Vaccinations

    Childhood Vaccinations
    The decision to vaccinate your children: a parents choice or public health risk? Last week, reality TV star Kristin Cavallari talked about about how she and her husband weren't vaccinating their children because she said, "I've read too many books about...
  • Seasonal Allergies

    Seasonal Allergies
    It just might be the only unwelcome sign of spring: Seasonal Allergies. The sniffling, sneezing and burning eyes are back. "The pollen count is higher than normal this year, mainly because of the prolonged cold we had in the winter", says FOXCT...
  • News of the Weird: Norway's Battle Against Chaos

    News of the Weird: Norway's Battle Against Chaos
    Norwegian public television (NRK), which introduced the now-legendary continuous, live log-burning show (12 hours long, with “color commentary” on the historical and cultural importance of fire), scheduled a new program for this week in its...
  • Baxter reports success in late-stage trial on extended release hemophilia drug

    Baxter reports success in late-stage trial on extended release hemophilia drug
    Baxter International Inc. said Thursday a key hemophilia drug under development met its primary goal in a late-stage clinical study. The drug, known as BAX 855, is essentially a stronger, extended-release version of its flagship hemophilia drug Advate,...
  • Lilly psoriasis drug impresses; battle nears with Amgen, Novartis

    (Reuters) - An experimental new psoriasis treatment from Eli Lilly and Co proved superior to Amgen Inc's blockbuster Enbrel, drawing it closer to a potential marketing battle with new products being developed by Amgen and Novartis AG. Based on...
  • Auxilium drug effective against cellulite in mid-stage study

    (Reuters) - Auxilium Pharmaceuticals Inc said two doses of its drug to smoothen cellulite were statistically significant in a mid-stage study, sending its shares up nearly 8 percent. There are no FDA-approved cellulite treatments and there is little...
  • Pfizer back for AstraZeneca? Year-end move seen most likely

    LONDON (Reuters) - Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion (71 billion pounds) takeover attempt in May. But while...
  • Glades Drugs opening headquarters in Lake Worth

    Glades Drugs opening headquarters in Lake Worth
    Glades Drugs, a pharmacy retailer owned and operated by pharmacists, is opening new headquarters in Lake Worth. The new 8,000-square-foot location at 4560 Lantana Road will feature office space, a lab and pharmacy. Glades Drugs, now based in Boca Raton,...
  • U.S. judge blocks FDA rule allowing generic versions of Hospira drug

    U.S. judge blocks FDA rule allowing generic versions of Hospira drug
    (Reuters) - A federal judge has issued a temporary restraining order against the U.S. Food and Drug Administration's decision to allow the sale of generic versions of the Hospira Inc sedative Precedex. Hospira filed a lawsuit in U.S. District Court in...
  • Allergan seeks deal with Salix to fend off Valeant: WSJ

    (Reuters) - Botox maker Allergan Inc has approached Salix Pharmaceuticals Ltd and at least one other company about a potential takeover in a bid to avert the $53 billion hostile takeover from Valeant Pharmaceuticals International Inc, the Wall Street...